Morgan Stanley downgraded Avalara from Overweight to Equal-Weight and set a new price target of $93.50 from $111.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/29/2022 | Mkt Outperform → Mkt Perform | JMP Securities | |
| 8/16/2022 | $111.00 → $93.50 | Overweight → Equal-Weight | Morgan Stanley |
| 8/15/2022 | Outperform → Mkt Perform | Raymond James | |
| 4/25/2022 | $140.00 → $100.00 | Buy → Neutral | BofA Securities |
| 2/11/2022 | $130.00 → $138.00 | Outperform | BMO Capital Markets |
| 2/11/2022 | $200.00 → $135.00 | Buy | Stifel |
| 2/11/2022 | $220.00 → $155.00 | Outperform | Raymond James |
| 2/11/2022 | $140.00 → $160.00 | Buy | Mizuho |
JMP Securities downgraded Avalara from Mkt Outperform to Mkt Perform
Morgan Stanley downgraded Avalara from Overweight to Equal-Weight and set a new price target of $93.50 from $111.00 previously
Raymond James downgraded Avalara from Outperform to Mkt Perform